10122-620 : Kengreal 50 mg Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 10122-620
Labeler: Chiesi USA, Inc.
Product Type: Human Prescription Drug
Drug Name:  Kengreal
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: NDA204958
Rev. Date: 


NDC Package Codes:

  • 10122-620-10: 10 VIAL, SINGLE‑USE IN 1 CARTON (10122‑620‑10) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, SINGLE‑USE (10122‑620‑01)

Active Ingredients:

  • Cangrelor

Dosage Strength:

  • 50 mg

Pharmaceutical Classes:

  • P2Y12 Platelet Inhibitor [EPC]
  • Decreased Platelet Aggregation [PE]
  • P2Y12 Receptor Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 65293-003 Kengreal 50 mg Intravenous Injection, Powder, Lyophilized, for Solution by The Medicines Company

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 10122-620 QR Code

< Prev: 10122-612Next: 10122-801 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.